Related Posts
Aurobindo Pharma Q2 net profit rises 9%
Aurobindo Pharma witnessed a nearly 9% surge in consolidated net profit for Q2FY25, reaching Rs 817 crore. This growth was fueled by an 8% rise […]
‘High-risk’ income tax refund claims under scanner
Authorities will systematically verify ‘high-risk’ income tax refund claims for the 2024-25 assessment year, following a standard operating procedure. Cases involving suspicious patterns, such as […]